Cargando…

Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk

Over the past decade, we have witnessed an exponential growth of interest into the role of endothelial progenitor cells (EPCs) in cardiovascular disease. While the major thinking revolves around EPC angiogenic repair properties, we have used a hypothesis-driven approach to discover disease-related d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, Nicola, Langford-Smith, Alexander W. W., Wilkinson, Fiona L., Alexander, M. Yvonne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048266/ https://www.ncbi.nlm.nih.gov/pubmed/30042945 http://dx.doi.org/10.3389/fmed.2018.00200

Ejemplares similares

Diabetic endothelial colony forming cells have the potential for restoration with glycomimetics
por: Langford-Smith, Alexander W. W., et al.
Publicado: (2019)

QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus
por: Edwards, Nicola, et al.
Publicado: (2018)

The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders
por: Milusev, Anastasia, et al.
Publicado: (2022)

Regulation of Endothelial Progenitor Cell Functions in Ischemic Heart Disease: New Therapeutic Targets for Cardiac Remodeling and Repair
por: Huang, Huai, et al.
Publicado: (2022)

The Interplay of SIRT1 and Wnt Signaling in Vascular Calcification
por: Bartoli-Leonard, Francesca, et al.
Publicado: (2018)

Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress
por: Mahmoud, Ayman M., et al.
Publicado: (2017)

Endothelial progenitor cells: a new player in lupus?
por: Haque, Sahena, et al.
Publicado: (2012)

Editorial: Chronic rheumatic inflammatory conditions and cardiovascular health
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

Endothelial progenitor cells in cardiovascular diseases: from biomarker to therapeutic agent
por: Liu, Hui-Bin, et al.
Publicado: (2013)

Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic Targets
por: Weidinger, Carl, et al.
Publicado: (2021)

Osteoprotegerin Induces CD34(+) Differentiation in Endothelial Progenitor Cells
por: Boisson-Vidal, Catherine, et al.
Publicado: (2018)

Endothelial Progenitor Cells and Cardiovascular Correlates
por: Mudyanadzo, Tatenda A
Publicado: (2018)

Endothelial progenitor cells in cardiovascular diseases
por: Qiu, Yumin, et al.
Publicado: (2018)

Recent Advances in Endothelial Progenitor Cells Toward Their Use in Clinical Translation
por: Keighron, Cameron, et al.
Publicado: (2018)

Editorial: Recent Advances in Endothelial Progenitor Cells Toward Their Use in Clinical Translation
por: Medina, Reinhold J., et al.
Publicado: (2020)

Cardioprotective Roles of Endothelial Progenitor Cell-Derived Exosomes
por: Zeng, Cai-Yu, et al.
Publicado: (2021)

Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases
por: Dagher, Olina, et al.
Publicado: (2021)

The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review
por: Ciaffi, Jacopo, et al.
Publicado: (2021)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

Downregulation of Endothelial Plexin A4 Under Inflammatory Conditions Impairs Vascular Integrity
por: Vreeken, Dianne, et al.
Publicado: (2021)

Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration
por: Kim, Hyunyun, et al.
Publicado: (2016)

Endoglin as an Adhesion Molecule in Mature and Progenitor Endothelial Cells: A Function Beyond TGF-β
por: Rossi, Elisa, et al.
Publicado: (2019)

Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
por: Aragona, Caterina Oriana, et al.
Publicado: (2016)

Exploring potential biomarkers and therapeutic targets of long COVID-associated inflammatory cardiomyopathy
por: Qi, Peng, et al.
Publicado: (2023)

Commentary: Renal Function Estimation and Cockcroft–Gault Formulas for Predicting Cardiovascular Mortality in Population-Based, Cardiovascular Risk, Heart Failure and Post-Myocardial Infarction Cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the High-Risk Myocardial Infarction Database Initiatives
por: Wilkinson, Thomas J., et al.
Publicado: (2017)

DPP3: From biomarker to therapeutic target of cardiovascular diseases
por: Ye, Peng, et al.
Publicado: (2022)

Latest Advances in Endothelial Progenitor Cell-Derived Extracellular Vesicles Translation to the Clinic
por: Salybekov, Amankeldi A., et al.
Publicado: (2021)

New Therapeutic Targets in Autoimmune Cholangiopathies
por: Gerussi, Alessio, et al.
Publicado: (2020)

Another win for endothelial progenitor cells: Endothelial progenitor cell-derived conditioned medium promotes proliferation and exerts neuroprotection in cultured neuronal progenitor cells
por: Sadanandan, Nadia, et al.
Publicado: (2019)

Editorial: The role of inflammation, stem cells and progenitor cells in cardiovascular repair
por: Kawaguchi, Nanako, et al.
Publicado: (2023)

Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications
por: Benítez-Camacho, Josefa, et al.
Publicado: (2023)

Glucocorticoid Impaired the Wound Healing Ability of Endothelial Progenitor Cells by Reducing the Expression of CXCR4 in the PGE2 Pathway
por: Carolina, Erica, et al.
Publicado: (2018)

Gut immune cells—A novel therapeutical target for cardiovascular disease?
por: Ganesh, Naresh, et al.
Publicado: (2022)

Inflammation in Cardiovascular Disease: A Comprehensive Review of Biomarkers and Therapeutic Targets
por: Gupta, Lovish, et al.
Publicado: (2023)

Endothelial Progenitor Cells Enter the Aging Arena
por: Williamson, K., et al.
Publicado: (2012)

Lymphangiogenesis in Inflammatory Bowel Disease; A New Therapeutic Target?
por: Koutroubakis, Ioannis E, et al.
Publicado: (2016)

Editorial: Vascular Endothelial Glycocalyx in Cardiovascular Disease
por: Tomita, Hiroyuki, et al.
Publicado: (2022)

Editorial: Endothelial-to-mesenchymal transition in cardiovascular disease
por: Alfaidi, Mabruka, et al.
Publicado: (2023)

Editorial: Novelties in the Therapeutic Approaches for Chronic Heart Failure: Cardiovascular Targets and Beyond
por: Sorgente, Antonio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2m07n4vbs2if3pb86f8btffmoa